The European Immunization Agenda 2030 (‎EIA2030)‎ is a vision and strategy, developed and adopted by all 53 Member States, for achieving the full benefits of vaccination in the WHO European Region. Building on the lessons learned and best practices identified in deploying COVID-19 vaccines, EIA2030 focuses on:

• strengthening national immunization policies;
• identifying and addressing gaps in immunization coverage;
• tailoring immunization service delivery to meet the needs of people and communities; and
• enhancing cross-sector partnerships and collaboration across regional, subregional and national institutions and platforms.

WHO contributes to EIA2030 implementation by providing technical support to Member States in areas such as disease surveillance, outbreak response, poliovirus containment, vaccine safety monitoring, behavioural insights research, communications and new vaccine introduction.

The resulting equitable expansion and uptake of vaccines will substantially reduce mortality and morbidity from vaccine-preventable diseases and help to prevent epidemics and pandemics in the future.

EIA2030 is accompanied by a detailed implementation framework and a compendium of indicators to enable monitoring and evaluation of progress.